ANDERSON RAYMOND sold 11.7% of their position (3.14K shares) of MONOPAR THERAPEUTICS on the open market
Open‑market sale worth $351.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/27/2026ACC: 0001437749-26-029115
-3.14K
Net shares
Net seller
$351.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
3.14K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−694.00
Price / share
$110.04
Trade value
$76.37K
% of position
2.6%
8/25/2026
26.86K→26.17K
Common Stock
Direct
Shares
−646.00
Price / share
$110.07
Trade value
$71.11K
% of position
2.5%
8/25/2026
26.17K→25.52K
Common Stock
Direct
Shares
−1.80K
Price / share
$113.05
Trade value
$203.72K
% of position
7.1%
8/25/2026
25.55K→23.75K
Total
Net shares
−3.14K
Net value
-$351.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/25/2026 | S · Sale | −694.00 | $110.04 | $76.37K | 2.6% | 26.86K | 26.17K |
| Common Stock Direct | 8/25/2026 | S · Sale | −646.00 | $110.07 | $71.11K | 2.5% | 26.17K | 25.52K |
| Common Stock Direct | 8/25/2026 | S · Sale | −1.80K | $113.05 | $203.72K | 7.1% | 25.55K | 23.75K |
| Total | −3.14K | -$351.19K | ||||||
Derivative Transactions0
No derivative transactions reported